Estrella Immunopharma annual operating expenses
2021
2022
2022
2023
2024
2024
2025
Estrella Immunopharma Operating Expenses Growth & History (ESLA)
Estrella Immunopharma's operating expenses was $13.1M for fiscal 2025.
View full Estrella Immunopharma company overviewEstrella Immunopharma annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $13.1M | $8.6M | +195.07% |
| 2024 · Dec 31 | 2024-12-31 | $4.4M | — | — |
| 2024 · Jun 30 | 2024-06-30 | $7.3M | −$3.8M | −34.23% |
| 2023 | 2023-06-30 | $11.1M | $9.4M | +559.47% |
| 2022 | 2022-12-31 | $1.4M | $1.2M | +664.40% |
| 2022 | 2022-06-30 | $1.7M | — | — |
| 2021 | 2021-12-31 | $178,992 | — | — |
Estrella Immunopharma quarterly operating expenses
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.1M | −$3.5M | −62.41% |
| Q1 2026 | 2026-03-31 | $2.3M | $187,766 | +8.92% |
| Q4 2025 | 2025-12-31 | $613,199 | — | — |
| Q3 2025 | 2025-09-30 | $4.8M | $1.4M | +42.18% |
| Q2 2025 | 2025-06-30 | $5.5M | $1.6M | +40.37% |
| Q1 2025 · Mar 31 | 2025-03-31 | $2.1M | $1.6M | +348.17% |
| Q1 2025 · Sep 30 | 2024-09-30 | $3.4M | $1.5M | +80.53% |
| Q4 2024 | 2024-06-30 | $3.9M | $3.8M | +2443.19% |
| Q3 2024 | 2024-03-31 | $469,530 | −$2.3M | −82.87% |
| Q2 2024 | 2023-12-31 | $1.0M | −$1.7M | −62.97% |
| Q1 2024 | 2023-09-30 | $1.9M | −$1.0M | −35.17% |
| Q4 2023 | 2023-06-30 | $155,295 | −$244,470 | −61.15% |
| Q1 2023 | 2023-03-31 | $2.7M | $2.6M | +2170.26% |
| Q4 2022 | 2022-12-31 | $2.8M | $2.6M | +1579.67% |
| Q3 2022 | 2022-09-30 | $2.9M | $2.9M | +27343.83% |
| Q2 2022 | 2022-06-30 | $399,765 | $396,206 | +11132.51% |
| Q1 2022 | 2022-03-31 | $120,740 | $119,921 | +14642.37% |
| Q4 2021 | 2021-12-31 | $164,100 | — | — |
| Q3 2021 | 2021-09-30 | $10,514 | — | — |
| Q2 2021 | 2021-06-30 | $3,559 | — | — |
| Q1 2021 | 2021-03-31 | $819 | — | — |
Estrella Immunopharma operating expenses trends
Between the periods ended 2021-12-31 and 2025-12-31, Estrella Immunopharma's operating expenses increased from $178,992 to $13.1M, a change of $12.9M. The latest reported quarter, Q2 2026, shows $2.1M.
About the metric
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
Calculation and source
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Estrella Immunopharma source filings ↗